Elevate Female
Natural health product licensed in Canada
- Licence holder
- Taylor and Zink Supplements Corp
- NPN or DIN-HM
- 80090876
- Status
- Active licence
- Licence date
- 22 February 2019
- Revision date
- 3 September 2026
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Conditions légales
Vitex agnus-castus L.: L'étiquetage doit comporter un avertissement déconseillant l'usage chez les femmes ayant des antécédents personnels ou familiaux de cancer du sein.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Lepidium meyenii Walp.: L'absence d'alcaloïdes doit être démontrée par des rapports d'analyse.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Foeniculum vulgare Mill.: La portion journalière recommandée ne doit pas conduire à une ingestion d'estragole supérieure à 0,05 mg/kg de poids corporel pour les enfants de moins de 12 ans.
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Vitex agnus-castus Source : Fruit | 50 mg | Not calculated |
| Lepidium meyenii Source : Racine Extract : Matériel brut sec Extraction ratio : 7.5:1 Dry plant equivalent : 1.5 g | 200 mg | Not calculated |
| Lepidium meyenii Source : Hypocotyle Extract : Matériel brut sec Extraction ratio : 7.5:1 Dry plant equivalent : 1.5 g | 200 mg | Not calculated |
| Foeniculum vulgare subsp. vulgare var. vulgare Source : Graine(s) | 100 mg | Not calculated |
| Extrait d'isoflavones de trèfle rouge Source : Extrait d'isoflavones de trèfle rouge | 80 mg | Not calculated |
Non-medicinal ingredients
Hypromellose, Extrait de ginseng
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19 years | 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Text supplied in English because no French text is available.
May reduce severe and frequent menopausal symptoms (such as hot flashes/flushes and/or night sweats). Helps to support healthy mood balance during menopause. Used in Herbal Medicine to help relieve symptoms associated with menopause, such as hot flushes and as a hormone normalizer to help stabilize menstrual cycle irregularities. Used in Herbal Medicine as a hormone normaliser to help stabilise menstrual cycle irregularities and relieve premenstrual symptoms.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Contre-indications
Do not use this product if you currently have or previously had breast cancer or if you have a predisposition to breast cancer, as indicated by an abnormal mammogram and/or biopsy, or if you have a family member with breast cancer. Do not use if you are allergic to anethole or plants of the Apiaceae/Carrot family. Do not use if you are pregnant, breastfeeding, or attempting to conceive unless you have consulted a health care practitioner/health care provider/health care professional/doctor/physician.
- Précautions et mises en garde
Consult a health care practitioner prior to use if you have high blood pressure or diabetes; are taking antidepressants or blood thinners, or digoxin; or suffer from any psychological disorder and/or condition such as frequent anxiety or depression. Consult a health care practitioner/health care provider/health care professional/doctor/ physician prior to use if you have a history of hormonal or gynecological disease (e.g. ovarian cancer, endometriosis and/or fibroids), are taking hormone replacement therapy, oral contraceptives or hormone-containing medications. Ensure that you are up-to-date on appointed clinical tests such as mammograms and endometrial ultrasounds or biopsies before using this product. Stop use and consult a health care practitioner/health care provider/health care professional/doctor/physician if you experience breast pain, discomfort, soreness and/or tenderness, abnormal uterine bleeding including spotting and/or recurrence of menstruation in postmenopausal women. Consult a health care practitioner if symptoms persist or worsen.
- Effets indésirables connus
Hypersensitivity (e.g. allergy) has been known to occur (rare cases); in which case, discontinue use. Stop use if you experience insomnia, anxiety or headaches.
Source
Official Health Canada record, licence 80090876
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.